Skip to content
Screener

Total Revenue at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$11.99B
Danaher logo
DanaherDHR
$6.27B+5.5%
Repligen logo
RepligenRGEN
$204.13M+11.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$592.1M+1.1%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$20.16M-48.5%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1B-2.7%

Segments

By geography

See full
Europe, the Middle East and Africa$10.45M+24.5%
Asia Pacific$9.32M+14.2%
Latin and Central America$386K+88.3%

Other financials

Income statement

See full
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001823239-26-000059
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$51,442$47,397$117,279$94,247
Cost of revenue30,79239,62962,92878,754
Gross profit20,6507,76854,35115,493
Operating expenses:
Selling, general and administrative32,07038,71561,16278,279
Research and development3,7024,8827,5919,770
Goodwill impairment30,44942,884
Restructuring(33)2,845

Item 1. Financial Statements

FAQ

What is Maravai LifeSciences Holdings, Inc.'s total revenue?
Maravai LifeSciences Holdings, Inc. (MRVI) reported total revenue of $51.44M in Q2 2026.
How has Maravai LifeSciences Holdings, Inc.'s total revenue changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s total revenue increased by 8.5% year-over-year, from $47.4M to $51.44M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s total revenue?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s total revenue has grown at a -30.6% compound annual growth rate (CAGR), from $799.24M to $185.74M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude